Research without borders: advancing equitable global partnerships to accelerate HBV elimination efforts [0.03%]
跨越边界的肝炎研究：推进公平的全球伙伴关系以加速消除乙型肝炎疫情
Enkhtuul Batbold,Rodrigue Kamga Wouambo,Teklu Shiferaw et al.
Enkhtuul Batbold et al.
Katrina Ray
Katrina Ray
ECCO'26 [0.03%]
ECCO'26（第26届欧洲组合大会）
Katrina Ray
Katrina Ray
Microplastics and nanoplastics in the human gut: from signals to standards [0.03%]
人体肠道内的微塑料和纳米塑料：从信号到标准
Brian D Deng,Sidhartha R Sinha,Gavin Lear et al.
Brian D Deng et al.
Metabotherapy for intestinal disease: using metabolites to prevent and treat disorders of the gut [0.03%]
肠道疾病的代谢疗法：利用代谢物预防和治疗肠道疾病
Shan Liu,Marina Domingo-Vidal,Bhoomi Madhu et al.
Shan Liu et al.
The gastrointestinal tract harbours a vast chemical diversity of small molecules, consisting of dietary nutrients, microorganism-derived metabolites and metabolic products of the host. The latest evidence highlights a direct involvement of ...
Yasser Fouad,Ming-Lung Yu,Saeed Hamid et al.
Yasser Fouad et al.
Reply to 'The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view' [0.03%]
对“原发性胆汁性胆管炎未经许可的治疗方法使用的伦理学：另一种观点”的回复
Christophe Corpechot,Maria-Carlota Londoño,Alejandra Villamil et al.
Christophe Corpechot et al.
The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view [0.03%]
原发性胆汁性胆管炎中未经批准的治疗方法使用的伦理问题：一种不同的观点
David E J Jones,Robert Mitchell-Thain,Emma L Culver et al.
David E J Jones et al.